The Federal Trade Commission will require Western Digital Corporation to sell assets used to manufacture and sell desktop hard disk drives to Toshiba Corporation as part of a proposed settlement that resolves charges that Western Digital’s proposed acquisition of rival Hitachi Global Storage Technologies Ltd. would likely have harmed competition in the market for desktop […]
Tag Archives: Competition
FTC Puts Conditions on Carpenter Technology Corporation’s Purchase of Rival Manufacturer Latrobe Specialty Metals, Inc.
The Federal Trade Commission will require specialty metals manufacturer Carpenter Technology Corporation to sell assets involved in producing two metal alloys used in the aerospace industry, under a proposed settlement resolving charges that Carpenter’s proposed $410 million acquisition of Latrobe Specialty Metals, Inc. would harm competition in the U.S. markets for these alloys. The proposed […]
FTC Seeks Public Comment on Cardinal Health, Inc.’s Application to Sell Nuclear Pharmacy Assets to Patient Care Infusion, LLC
The Federal Trade Commission is seeking public comment on an application by Cardinal Health, Inc., which is requesting approval to sell former Cardinal Health nuclear pharmacy assets to Patient Care Infusion, LLC. Cardinal’s sale of the assets is required under a 2011 settlement with the FTC, which resolved charges that Cardinal’s acquisition of three nuclear […]
Omnicare Abandons Plan to Buy Rival Pharmacy in Light of FTC Lawsuit; FTC Votes to Dismiss its Complaint Seeking to Block the Transaction
The Federal Trade Commission has dismissed the complaint it issued in January seeking to block Omnicare, Inc.’s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, in light of Omnicare’s recent decision to abandon the proposed transaction. The Commission voted 4-0 to dismiss the complaint, after Omnicare announced on Tuesday that it had allowed […]
FTC Approves Final Orders Settling Charges that Valeant Pharmaceuticals International Inc.’s Proposed Acquisitions of Dermatology Businesses from Sanofi and Johnson & Johnson were Anticompetitive
Following public comment periods for both transactions, the Federal Trade Commission has approved final orders settling charges that Valeant Pharmaceuticals International, Inc.’s (Valeant) two proposed acquisitions of dermatology businesses – one from Sanofi and one from Johnson & Johnson – would have been anticompetitive and in violation of Section 7 of the Clayton Act and […]
FTC Approves Final Order Settling Charges that LabCorp’s Proposed Acquisition of Orchid Cellmark Inc. was Anticompetitive in Market for Paternity Testing Services
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Laboratory Corporation of America Holdings’ (LabCorp) proposed acquisition of rival firm Orchid Cellmark Inc. (Orchid) would have illegally reduced competition in the U.S. market for paternity testing services provided to government agencies. The final order settling the FTC’s […]
FTC Sues to Block Omnicare’s Bid to Buy Rival Pharmacy Provider PharMerica
The Federal Trade Commission issued a complaint to block Omnicare, Inc.’s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others. In its complaint, […]
FTC Seeks Public Comment on Healthcare Technology’s Application to Sell SDI Health’s Audit Businesses
The Federal Trade Commission seeks public comment on an application by Healthcare Technology Holdings, Inc., which is requesting approval to sell two audit businesses of SDI Health LLC to inVentiv Health, Inc. A divestiture is required by the final FTC settlement order allowing Healthcare Technology’s subsidiary IMS Health Inc. to acquire SDI Health. According to […]
FTC Announces Revised Thresholds for Clayton Act Antitrust Reviews
The Federal Trade Commission announced it has revised the thresholds that determine whether companies are required to notify federal antitrust authorities about a transaction under the Hart-Scott-Rodino Antitrust Improvements Act. These filing thresholds are required to be adjusted annually to keep pace with inflation, unlike the pre-merger filing fees, which have not changed in more […]
FTC Approves Universal Health Services’ Application to Sell Puerto Rico Assets
Following a public comment period, the Federal Trade Commission has approved an application by Universal Health Services, Inc. to sell what are known as the Puerto Rico Divestiture Assets, including Hospital San Juan Capestrano and its affiliated outpatient centers, to Donald R. Dizney and David A. Dizney, through two companies that are members of the […]